butyric acid has been researched along with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anjomshoa, M; Azadegan-Dehkordi, F; Bagheri, N; Beshkar, P; Majidi, J; Mirzaei, Y; Mohammad-Rezaei, M; Mokhtarian, K; Soltani, M | 1 |
| Lazo-Gómez, R; Prior-González, M; Tapia, R | 1 |
2 other study(ies) available for butyric acid and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
| Article | Year |
|---|---|
A Study of Autoantibodies against Some Central Nervous System Antigens and the IL-35 Serum Level in Schizophrenia.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Aquaporins; Autoantibodies; Butyric Acid; Case-Control Studies; Cell Adhesion Molecules, Neuronal; Central Nervous System; Cytokines; Humans; Interleukins; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Peptide Hydrolases; Potassium Channels, Voltage-Gated; Receptors, Cholinergic; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2022 |
Sodium butyrate does not protect spinal motor neurons from AMPA-induced excitotoxic degeneration in vivo.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amyotrophic Lateral Sclerosis; Animals; Butyric Acid; Humans; Motor Neurons; Spinal Cord | 2023 |